Literature DB >> 11520607

Hepatitis C virus core protein: intriguing properties and functional relevance.

R B Ray1, R Ray.   

Abstract

Hepatitis C virus (HCV) often causes a prolonged and persistent infection, and an association between hepatocellular carcinoma (HCC) and HCV infection has been noted. The pathogenesis of liver damage is at least in part related to virus-mediated factors. Understanding the molecular basis of pathogenesis is a major challenge in gaining insight into HCV-associated disease progression. Recent experimental evidence using HCV cloned genomic regions suggests that the core protein has numerous functional activities. These include its likely role in encapsidation of viral RNA, a regulatory effect on cellular and unrelated viral promoters, interactions with a number of cellular proteins, an modulatory role in programmed cell death or apoptosis under certain conditions, involvement in cell growth promotion and immortalization, induction of HCC in transgenic mice, and a possible immunoregulatory role. These intriguing properties suggest that the core protein, in concert with cellular factors, may contribute to pathogenesis during persistent HCV infection.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11520607     DOI: 10.1111/j.1574-6968.2001.tb10796.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  39 in total

1.  SOCS1 and SOCS3 are targeted by hepatitis C virus core/gC1qR ligation to inhibit T-cell function.

Authors:  Zhi Qiang Yao; Stephen N Waggoner; Michael W Cruise; Caroline Hall; Xuefang Xie; David W Oldach; Young S Hahn
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

2.  Functional replacement of a domain in the rubella virus p150 replicase protein by the virus capsid protein.

Authors:  Wen-Pin Tzeng; Teryl K Frey
Journal:  J Virol       Date:  2009-01-28       Impact factor: 5.103

3.  Hepatitis C virus-host interactions: Etiopathogenesis and therapeutic strategies.

Authors:  Mohamed Hassan; Denis Selimovic; Abdelouahid El-Khattouti; Hanan Ghozlan; Youssef Haikel; Ola Abdelkader
Journal:  World J Exp Med       Date:  2012-04-20

4.  Hepatitis C virus core protein is a dimeric alpha-helical protein exhibiting membrane protein features.

Authors:  Steeve Boulant; Christophe Vanbelle; Christine Ebel; François Penin; Jean-Pierre Lavergne
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

5.  Proapoptotic and pronecrosis effect of different truncated hepatitis C virus core proteins.

Authors:  Xue-bing Yan; Zhi Chen; Dong-hui Luo; Xiao-yan Xu; Wei Wu; Lin-fu Zhou
Journal:  J Zhejiang Univ Sci B       Date:  2005-04       Impact factor: 3.066

6.  NF-kappaB signaling mediates the induction of MTA1 by hepatitis B virus transactivator protein HBx.

Authors:  T M Bui-Nguyen; S B Pakala; R D Sirigiri; W Xia; M-C Hung; S K Sarin; V Kumar; B L Slagle; R Kumar
Journal:  Oncogene       Date:  2009-12-14       Impact factor: 9.867

7.  Targeting of hepatitis C virus core protein to mitochondria through a novel C-terminal localization motif.

Authors:  Björn Schwer; Shaotang Ren; Thomas Pietschmann; Jürgen Kartenbeck; Katrin Kaehlcke; Ralf Bartenschlager; T S Benedict Yen; Melanie Ott
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

8.  The hepatitis C virus core protein contains a BH3 domain that regulates apoptosis through specific interaction with human Mcl-1.

Authors:  Nur Khairiah Mohd-Ismail; Lin Deng; Sunil Kumar Sukumaran; Victor C Yu; Hak Hotta; Yee-Joo Tan
Journal:  J Virol       Date:  2009-07-15       Impact factor: 5.103

9.  Hepatitis C virus core protein and cellular protein HAX-1 promote 5-fluorouracil-mediated hepatocyte growth inhibition.

Authors:  Arup Banerjee; Kousuke Saito; Keith Meyer; Sutapa Banerjee; Malika Ait-Goughoulte; Ratna B Ray; Ranjit Ray
Journal:  J Virol       Date:  2009-07-15       Impact factor: 5.103

10.  Requirement of cellular DDX3 for hepatitis C virus replication is unrelated to its interaction with the viral core protein.

Authors:  Allan G N Angus; David Dalrymple; Steeve Boulant; David R McGivern; Reginald F Clayton; Martin J Scott; Richard Adair; Susan Graham; Ania M Owsianka; Paul Targett-Adams; Kui Li; Takaji Wakita; John McLauchlan; Stanley M Lemon; Arvind H Patel
Journal:  J Gen Virol       Date:  2009-09-30       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.